TherapeuticsMD (TXMD) Reports In-Line Q4 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Wall St falls as oil ticks up, yields rise ahead of US-China summit
- BTIG’s Krinsky warns 2000-like signals are mounting
- HSBC remains max bullish on stocks, tells investors to lean into tech
- Analyst explains why the midterm outcome is a “fundamental non-event”
- Oil holds near two-week lows while diesel cracks hit record
TherapeuticsMD Announces Fourth Quarter and Full-Year 2018 Financial Results
February 21, 2019 4:05 PM EST
Successful Launch of IMVEXXY®, Strong Positive
Trends
Continue for Prescriptions and Patient Refills
BIJUVA Commercial Launch on Track for the Second Quarter of 2019
ANNOVERA Commercial Launch planned as Early as the Third Quarter of 2019
Conference Call Scheduled for 4:30 p.m. ET Today
BOCA RATON, Fla.--(BUSINESS WIRE)-- TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading womens healthcare company, today announced its commercial and corporate update for the fourth quarter and full-year ended December 31, 2018.
In 2018, we completed our most successful... More
